C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Applied BioMath, LLC Announces Collaboration with Asher Biotherapeutics for Systems Pharmacology Modeling in Oncology

Wednesday, March 31, 2021

Applied BioMath wwwappliedbiomathcom the industryleader in applying systems pharmacology and mechanistic modeling simulation and analysis to derisk drug research and development announced a collaboration with Asher Biotherapeutics for systems pharmac...

BridGene Biosciences Announces Research Collaboration with Takeda to Discover Small Molecule Drugs for "Undruggable" Targets

Wednesday, March 31, 2021

BridGene Biosciences Inc a biotechnology company using cuttingedge technology to discover and develop small molecules for hardtodrug therapeutic targets announced a strategic research collaboration and licensing agreement with Takeda Pharmaceutical C...

Hansa Biopharma enters preclinical research collaboration with argenx

Tuesday, March 30, 2021

Hansa Biopharma AB Hansa a pioneer in enzyme technology for rare immunological conditions announced that they have entered into a preclinical research collaboration agreement with argenx BV to evaluate the therapeutic potential of combining the two c...

Tarsus Pharmaceuticals and LianBio Announce Strategic Partnership to Develop and Commercialize TP-03 in Greater China

Tuesday, March 30, 2021

Tarsus Pharmaceuticals Inc a late clinicalstage biopharmaceutical company and LianBio a biotechnology company dedicated to bringing paradigmshifting medicines to patients in China and major Asian markets announced a strategic partnership to develop a...

Astellas Receives Positive CHMP Opinion for XTANDITM (enzalutamide) for Patients with Metastatic Hormone-Sensitive Prostate Cancer

Monday, March 29, 2021

Astellas Pharma Incannounced the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has adopted a positive opinion recommending an additional indication for the oral oncedaily therapy XTANDITM enzalutamide for ad...

Bright Peak Therapeutics Inc. and Ajinomoto Co., Inc. Enter into a Research Collaboration and License Agreement to Create Novel Immunocytokines

Friday, March 26, 2021

Bright Peak Therapeutics Inc a biotechnology company developing next generation immunotherapies for cancer and autoimmune disease and Ajinomoto Co Inc Ajinomoto Co a leading technology provider for biopharmaceuticals and the owner of Ajinomoto BioPha...

Twist Bioscience and Kyowa Kirin Partner for GPCR Antibody Discovery

Friday, March 26, 2021

Twist Bioscience Corporation a company enabling customers to succeed through its offering of highquality synthetic DNA using its silicon platform today announced that it signed a partnership agreement with Kyowa Kirin Pharmaceutical Research Inc a su...

Exacis Biotherapeutics Develops mRNA-Engineered iPSC-Derived NK Cells For Difficult-To-Treat Tumors

Thursday, March 25, 2021

Exacis Biotherapeutics Inc a developmentstage immunooncology company working to democratize access to the most advanced and effective cancer treatments announced several important steps in the preclinical development of its ExaNK engineered NK cellth...

Biopharmaceutical and technology leaders form collaboration to promote standards and a modern patient ID for advanced therapies

Thursday, March 25, 2021

A broad coalition of biopharmaceutical and technology leaders announced a new strategic collaboration to promote new and updated standards for advanced therapies The new collaboration which will work across the biopharmaceutical and technology sector...

Dunad Therapeutics Emerges To Develop Next-generation Small Molecule Therapeutics Based On First Tuneable Targeted Protein Degradation Technology

Wednesday, March 24, 2021

Dunad Therapeutics Dunad emerges to develop nextgeneration small molecule therapeutics based on its highly differentiated tuneable and targeted protein degradation technology Dunad secured initial financing from Epidarex Capital

Latest Issue
Get instant
access to our latest e-book
Saving Money, Saving Time In Pharma Operations